Dr. Kane on Genetic Testing for Prostate Cancer

Christopher J. Kane, MD
Published Online: Wednesday, Apr 19, 2017



Christopher J. Kane, MD, professor of Surgery, chair, Department of Urology, UC San Diego Health, discusses the impact of genetic testing on patients with prostate cancer.

Genetic testing for patients with prostate cancer can have a broad impact on who needs to be screened and who can benefit from screening. Many times, when patients come in for screening, they don’t know their family history, explains Kane.

The genomic risk that might be inherited in your germline could influence the type of prostate cancer a patient could have and how sensitive that prostate cancer is to different types of treatment, states Kane.



Christopher J. Kane, MD, professor of Surgery, chair, Department of Urology, UC San Diego Health, discusses the impact of genetic testing on patients with prostate cancer.

Genetic testing for patients with prostate cancer can have a broad impact on who needs to be screened and who can benefit from screening. Many times, when patients come in for screening, they don’t know their family history, explains Kane.

The genomic risk that might be inherited in your germline could influence the type of prostate cancer a patient could have and how sensitive that prostate cancer is to different types of treatment, states Kane.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
$emailPop$
x